HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alberto Oliaro Pier Luigi Filosso Roberto Giobbe Paraskevas Lyberis Riccardo Carlo Cristofori Enrico Ruffini Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oliaro, A. Articles by Ruffini, E. Search for Related Content PubMed Articles by Oliaro, A. Articles by Ruffini, E. Related Collections Lung - cancer

The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system

Department of Thoracic Surgery, University of Torino, Italy

Received 11 September 2007; received in revised form 26 March 2008; accepted 31 March 2008.

^_* Corresponding author. Address: Dipartimento Fisiopatologia Clinica, Sezione di Chirurgia Toracica, Università degli Studi di Torino, Ospedale Molinette, Via Genova 3, 10126 Torino, Italy. Tel.: +39 011 6705380; fax: +39 011 6705365. (Email: enrico.ruffini{at}unito.it).

Objective: The management of patients with non-small cell lung cancer (NSCLC) with intrapulmonary metastases (PM) is controversial. In TNM classification, PM are designed as T4 when in the same lobe of the primary tumour (PM1) and M1 when in a different lobe(s) (PM2). Some authors have questioned the negative prognostic impact of PM. The present study assessed prevalence, correlation with clinico-pathologic variables and impact on survival of PM, along with a review of the literature. Methods: From January 1993 to December 2006, 2013 NSCLC patients underwent surgical resection at our institution. Of these, 74 presented with PM (39 PM1, 35 PM2). Patients with bronchioloalveolar carcinoma (BAC), carcinoid tumours, contralateral disease and preoperative chemo/radiotherapy were excluded from the analysis. A logistic regression analysis was undertaken to evaluate a relationship between the presence of PM and different clinico-pathologic variables. Survival analysis was undertaken to investigate the prognostic significance of PM. Results: PM represent 3.6% of our patient population of operated NSCLC. Metastases were multiple in 36 cases and single in 38. Thirty-six patients had node-negative disease. Among all the variables for the logistic regression analysis only vascular invasion (OR: 0. 45; 95% CI 0.24–0.85, p = 0.01) and N status (OR: 0. 6; 95% CI 0.43–0.82, p = 0.001) were significantly correlated with the presence of PM. Median survival rates of PM1, PM2, other T4 and other M1 patients were 25, 23, 15 and 14 months, respectively. A survival advantage was observed in patients with PM as compared to other T4/M1 patients, although the difference was not significant either overall (p = 0.21) or in the N0 disease group (p = 0.12). Conclusions: The presence of PM in NSCLC patients is a rare occurrence. Risk factors for the development of PM are a microscopic vascular invasion and a high nodal status. A survival advantage over other T4/M1 patients is evident from our experience, although not significant. The results of the literature which have been accumulating in the most recent years including ours bend to the conclusion that there is sufficient validated information to consider a downstaging in the presence of intrapulmonary metastases from NSCLC for the seventh edition of the TNM classification.

Key Words: Non-small cell lung cancer • Intrapulmonary metastases • Surgery • TNM staging system

This article has been cited by other articles:

				N. Girard, I. Ostrovnaya, C. Lau, B. Park, M. Ladanyi, D. Finley, C. Deshpande, V. Rusch, I. Orlow, W. D. Travis, et al. Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non-Small Cell Lung Cancers Clin. Cancer Res., August 15, 2009; 15(16): 5184 - 5190. [Abstract] [Full Text] [PDF]